Catalyst Wire Dossier Catalyst Wire Dossier

Tetravalent Inactivated Enterovirus Vaccine (Vero Cell)

tetravalent inactivated enterovirus vaccine · Sinovac Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). [Phase 1, Phase 2]

See pricing